DONATE NOW

DONATE

About
Resources
Research
- Cohort Studies & Epidemiology
- Social & Community-based Research
- Clinical Research
- Program Evaluation
Education
Care Guidance
Publications
News
- News
- Blog
- News Releases

Article: Benzodiazepine use and hepatitis C seroconversion in a cohort of persons who inject drugs

Article: Benzodiazepine use and hepatitis C seroconversion in a cohort of persons who inject drugs

Article: Benzodiazepine use and hepatitis C seroconversion in a cohort of persons who inject drugs

June 17, 2016

← Prev Post
Next Post →

Share

BC Centre on Substance Use

400-1045 Howe St, Vancouver, BC V6Z 2A9

E: [email protected] | T: (778) 945-7616 | F: (604) 428-5183

24/7 Addiction Clinician Support Line: (778) 945-7619

Online Addiction Medicine Diploma: [email protected].

Copyright © 2023, BC Centre on Substance Use

Login
Login
Username or Email Address
Password
Remember Me

Your ticket for the: Article: Benzodiazepine use and hepatitis C seroconversion in a cohort of persons who inject drugs

Title

Article: Benzodiazepine use and hepatitis C seroconversion in a cohort of persons who inject drugs

USD